Company Filing History:
Years Active: 2009
Title: Tom Stefanac: Innovator in Pharmaceutical Chemistry
Introduction
Tom Stefanac is a notable inventor based in Mississauga, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the brain.
Latest Patents
Tom Stefanac holds a patent for "Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists." This invention is directed to compounds of formula I, wherein various components are defined in the description. The patent also encompasses processes for the preparation of these compounds, new intermediates used in their preparation, pharmaceutical compositions containing the compounds, and their therapeutic applications.
Career Highlights
Tom Stefanac is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work focuses on innovative solutions that address unmet medical needs through advanced research and development.
Collaborations
Throughout his career, Tom has collaborated with esteemed colleagues, including David Wensbo and Martin Johansson. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Tom Stefanac's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in the medical field. His work continues to influence the development of new therapeutic options for patients.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.